Successful use of long acting octreotide in two cases with Beckwith-Wiedemann syndrome and severe hypoglycemia
Conclusion:
Successful treatment of hypoglycemia can be achieved and maintained with LAR in infants and children with BWS who are either resistant or cannot tolerate diazoxide.
Source: International Journal of Pediatric Endocrinology - Category: Endocrinology Authors: Hiba Al-ZubeidiMichael GottschalkRon Newfield Source Type: research
More News: Children | Endocrinology | Genetics | Hydrocortisone | Hypertrichosis | Parenteral Nutrition | Pediatrics